Journey Medical (DERM) Cash from Operations (2020 - 2026)
Journey Medical's (DERM) quarterly Cash from Operations came in at 2909000.0 in Q1 2026, up 202.72% YoY from 960957.42 in Q1 2025, and up 146.29% on a QoQ basis from 6284000.0 in Q4 2025.
Journey Medical (DERM) Cash from Operations (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Cash from Operations data on file, last reported at 2909000.0 in Q1 2026.
- Quarterly Cash from Operations rose 202.72% year-over-year to 2909000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6700000.0 (up 3.46% YoY) and the FY2025 annual result came in at 12441000.0, down 36.31% from the prior year.
- Cash from Operations rose to 2909000.0 in Q1 2026, from 6284000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 18747000.0 in Q3 2023 to a low of 16520000.0 in Q4 2023.
- A 5-year average of 1585470.59 and a median of 2383000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 357.44% — and 2024, when it tumbled 425.0%.
- Tracing DERM's Cash from Operations over 5 years: stood at 3836000.0 in 2022, then slumped by 330.66% to 16520000.0 in 2023, then soared by 113.47% to 2225000.0 in 2024, then slumped by 382.43% to 6284000.0 in 2025, then surged by 146.29% to 2909000.0 in 2026.
- The last three Cash from Operations figures came in at 2909000.0 (Q1 2026), 6284000.0 (Q4 2025), and 2383000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -942,000.00 |
| Jun 30, 2025 | -942,000.00 |
| Mar 31, 2025 | -2.83 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -5.18 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Mar 31, 2024 | -5.02 Mn |